SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Guggenheim Upgrades Allogene Therapeutics to Buy

Guggenheim upgrades Allogene Therapeutics (NASDAQ:ALLO) from Neutral to Buy.

Benzinga · 05/15/2020 11:06

Guggenheim upgrades Allogene Therapeutics (NASDAQ:ALLO) from Neutral to Buy.